Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
[Fampridine and multiple sclerosis.]
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
Multiple sclerosis: getting personal with induced pluripotent stem cells.
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
A 62-year-old man with fluctuating neurological deficits and skin lesions.
Sonic Hedgehog Signaling Is a Positive Oligodendrocyte Regulator during Demyelination.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
B cells in MS and NMO: pathogenesis and therapy.
Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Endocannabinoids and the Immune System in Health and Disease.
Resting-State fMRI in MS: General Concepts and Brief Overview of Its Application.
Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Cerebrospinal fluid derived immunoglobulin G of different multiple sclerosis patients share mutated sequences in complementarity determining regions.
The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis.
Brain radiation and possible presentation of multiple sclerosis.

Pages